跳至主要内容
临床试验/NCT07709741
NCT07709741尚未招募1 期

Sustained Release Oral Formulation For Treatment Of Parkinsons Disease

University of Minnesota1 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2026年9月30日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
尚未招募
入组人数
32
试验地点
1
主要终点
Blood CD Level - Minute 15

研究概览

简要总结

LD/CD (medications to treat Parkinson's disease) will be delivered using an assembly of nested sachets made of permeable material. The assembly is placed in the oral/buccal cavity (between cheek and gum of lower jaw) and delivers continuous release of CD and LD for both transmucosal and gastrointestinal absorption. The combination of CD/LD in the inner sachet varies from that in the outer sachet. This allows for sequential release of CD and then LD to mimic a CD pretreatment method which is known to increase LD absorption and prolong its half-life.

详细描述

This is a randomized, double-blind (dose-masked), single-dose crossover study to investigate the pharmacokinetics of a novel delivery method and formulation of different doses of CD/LD in normal volunteers.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Other
盲法
Double (Participant, Care Provider)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Adult healthy male or female
  • •Age 18 to 65 years
  • •Willingness and ability to complete study procedures

排除标准

  • •medical conditions that require taking medications regularly.

研究组 & 干预措施

Formulation A

Active Comparator

Two sachets nested between the lower jaw, gum, and cheek; outer sachet 100 mg CD/0mg LD and inner sachet 0mg CD /400mg LD

干预措施: Formulation A (Drug)

Formulation B

Active Comparator

Two sachets nested between the lower jaw, gum, and cheek; outer sachet 150mg CD/0mg LD and inner sachet 600mg LD

干预措施: Formulation B (Drug)

Formulation C

Active Comparator

Two sachets nested between the lower jaw, gum, and cheek; outer sachet 200mg CD/0mg LD and inner sachet 800mg LD

干预措施: Formulation C (Drug)

结局指标

主要结局

Blood CD Level - Minute 15

时间窗: Minute 15 after administration

Measured in \[ng/mL\]

Blood LD Level - Minute 15

时间窗: Minute 15 after administration

Measured in \[ng/mL\]

Blood CD Level - Minute 30

时间窗: Minute 30 after administration

Measured in \[ng/mL\]

Blood LD Level - Minute 30

时间窗: Minute 30 after administration

Measured in \[ng/mL\]

Blood CD Level - Minute 45

时间窗: Minute 45 after administration

Measured in \[ng/mL\]

Blood LD Level - Minute 45

时间窗: Minute 45 after administration

Measured in \[ng/mL\]

Blood CD Level - Hour 1

时间窗: One hour after administration

Measured in \[ng/mL\]

Blood LD Level - Hour 1

时间窗: One hour after administration

Measured in \[ng/mL\]

Blood CD Level - Hour 2

时间窗: Two hours after administration

Measured in \[ng/mL\]

Blood LD Level - Hour 2

时间窗: Two hours after administration

Measured in \[ng/mL\]

Blood CD Level - Hour 3

时间窗: Three hours after administration

Measured in \[ng/mL\]

Blood LD Level - Hour 3

时间窗: Three hours after administration

Measured in \[ng/mL\]

Blood CD Level - Hour 4

时间窗: Four hours after administration

Measured in \[ng/mL\]

Blood LD Level - Hour 4

时间窗: Four hours after administration

Measured in \[ng/mL\]

Blood CD Level - Hour 5

时间窗: Five hours after administration

Measured in \[ng/mL\]

Blood LD Level - Hour 5

时间窗: Five hours after administration

Measured in \[ng/mL\]

Blood CD Level - Hour 6

时间窗: Six hours after administration

Measured in \[ng/mL\]

Blood LD Level - Hour 6

时间窗: Six hours after administration

Measured in \[ng/mL\]

Blood CD Level - Hour 7

时间窗: Seven hours after administration

Measured in \[ng/mL\]

Blood LD Level - Hour 7

时间窗: Seven hours after administration

Measured in \[ng/mL\]

Blood CD Level - Hour 8

时间窗: Eight hours after administration

Measured in \[ng/mL\]

Blood LD Level - Hour 8

时间窗: Eight hours after administration

Measured in \[ng/mL\]

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验